Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis
Journal of Drugs in Dermatology · 2023
DOI: 10.36849/jdd.7497 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Journal of Drugs in Dermatology, 2023. Verfasst von Christina L Kontzias und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatologic Agents, Psoriasis. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Kontzias, C. L., Curcio, A., Gorodokin, B., Tissera, K. A., Feldman, S. R., Bhatia, N., Callender, V. D., & Kircik, L. (2023). Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7497
Vancouver
Kontzias CL, Curcio A, Gorodokin B, Tissera KA, Feldman SR, Bhatia N, et al. Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7497
BibTeX
@article{Kontzias2023,
author = {Kontzias, Christina L and Curcio, Alyssa and Gorodokin, Brandon and Tissera, Kristin A and Feldman, Steven R and Bhatia, Neal and Callender, Valerie D and Kircik, Leon},
title = {Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis},
journal = {Journal of Drugs in Dermatology},
year = {2023},
doi = {10.36849/jdd.7497}
}
EUVIMED